Injectable ipamorelin maintains its five-amino-acid sequence (Aib-His-D-2-Nal-D-Phe-Lys-NH2) through circulation, while oral forms degrade into non-functional fragments
Clinical trial data showed similar weight loss outcomes between formulations when treatment was adhered to
Semaglutide (also injected weekly) was associated with an average weight loss of around 11% after 24 to 68 weeks, with evidence suggesting the effect can persist for up to two years, based on 18 randomized controlled trials (27 949 participants)
Leptin, which signals fullness, tends to decrease
Weight loss potential Early data suggests that cagrilintide, especially in combination with semaglutide, may offer superior weight loss compared to orlistat
It sells medication at very low prices